We are in a time where obesity, and its associated economic burdens, is a worldwide problem1. Two out of every three Americans are overweight or obese with related heart pathologies, the primary cause of death within the adult population2. New efficient methods are needed to adequately investigate the genetic and molecular components implicated in the regulation of metabolic syndrome using model organisms. For this reason, we choose the fruit fly Drosophila model because it shares the most basic biological processes with mammals, including mice and humans3,4,5,6. Drosophila's genome is highly conserved during evolution but overall much smaller with less gene duplication and metabolic complexity, making it ideal for understanding the fundamental mechanisms implicated in many human diseases4,7,8. Also, characteristic processes carried out by adipose tissue, the gut and pancreas are represented in the fly and mediate regulatory functions in glucose and lipid metabolism, for example, that are similar to humans9,10,11. Moreover, the basic molecular pathways involved in the control of obesity, insulin resistance and diabetes in humans are functionally conserved in Drosophila melanogaster12,13,14,15,16. Like higher organisms, Drosophila has a beating heart that is formed during development by similar processes to that of the mammalian heart3,17. Thus, the development of a reliable HFD feeding protocol and high throughput TAG assay, adapted for efficient screening purposes using the genetic tool box of Drosophila, provide an important means to study and understand the fundamental genetic basis underlying complex metabolic diseases.
The HFD food itself is made from a standard laboratory fly food supplemented with coconut oil, which is composed mostly of saturated fatty acids known to be associated with metabolic syndrome18. While inducing obesity in mammalian models, such as rodents, can take months19,20, our optimized HFD feeding protocol in Drosophila effectively and reproducibly increases organismal fat content in a matter of days12,14. This protocol, in conjunction with a high throughput TAG assay, allows efficient mass screening for the effects of genetic factors, environmental influences and drug candidates to discover new modulators of fat metabolism. In consequence, these protocols are likely relevant to understand and/or combat obesity and obesity-associated human pathologies.
The feeding protocol is versatile and may be applied to study the metabolic and functional effects of single saturated or unsaturated fatty acid. The use of this high throughput TAG assay is not limited to D. melanogaster, but may be adapted to a variety of small model organisms with cuticle or tough extracellular matrices (e.g., other Drosophila species, C. elegans and other emerging invertebrate model organisms) to measure fat content under different environmental, genetic or physiological conditions, at any stage of development, adulthood or phase of metabolic disease. The TAG assay is based on a colorimetric measurement of a series of enzymatic reactions that degrade the TAGs into free fatty acids, glycerol, Glycerol 3-phosphate and finally H2O2 that reacts with 4-aminoantipyrine (4-AAP) and 3,5-dichloro-2-hydroxybenzene sulfonate (3,5 DHBS) to produce a red colored product that is measured using a 96-well spectrophotometer.